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Abstract
Background: Particulate matter (PM) is one of the six criteria pollutant classes for which National Ambient Air
Quality Standards have been set by the United States Environmental Protection Agency. Exposures to PM have
been correlated with increased cardio-pulmonary morbidity and mortality. Butadiene soot (BDS), generated from
the incomplete combustion of 1,3-butadiene (BD), is both a model PM mixture and a real-life example of a
petrochemical product of incomplete combustion. There are numerous events, including wildfires, accidents at
refineries and tank car explosions that result in sub-acute exposure to high levels of airborne particles, with the
people exposed facing serious health problems. These real-life events highlight the need to investigate the health
effects induced by short-term exposure to elevated levels of PM, as well as to assess whether, and if so, how well
these adverse effects are resolved over time. In the present study, we investigated the extent of recovery of mouse
lungs 10 days after inhalation exposures to environmentally-relevant levels of BDS aerosols had ended.
Methods: Female BALB/c mice exposed to either HEPA-filtered air or to BDS (5 mg/m3 in HEPA filtered air, 4 h/day,
21 consecutive days) were sacrificed immediately, or 10 days after the final BDS exposure. Bronchoalveolar lavage
fluid (BALF) was collected for cytology and cytokine analysis. Lung proteins and RNA were extracted for protein and
gene expression analysis. Lung histopathology evaluation also was performed.
Results: Sub-acute exposures of mice to hydrocarbon-rich ultrafine particles induced: (1) BALF neutrophil elevation;
(2) lung mucosal inflammation, and (3) increased BALF IL-1β concentration; with all three outcomes returning to
baseline levels 10 days post-exposure. In contrast, (4) lung connective tissue inflammation persisted 10 days
post-exposure; (5) we detected time-dependent up-regulation of biotransformation and oxidative stress genes,
with incomplete return to baseline levels; and (6) we observed persistent particle alveolar load following
10 days of recovery.
Conclusion: These data show that 10 days after a 21-day exposure to 5 mg/m3 of BDS has ended, incomplete lung
recovery promotes a pro-biotransformation, pro-oxidant, and pro-inflammatory milieu, which may be a starting point
for potential long-term cardio-pulmonary effects.
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Background
Particulate matter (PM) is one of the six criteria pollutant
classes for which National Ambient Air Quality Standards
have been set by the United States Environmental Protec-
tion Agency [1]. PM is ubiquitous in outdoor air and con-
tributes significantly to air pollution, especially in urban
areas [2, 3]. PM are composed of ambient coarse
(PM10, < 10 μm), fine (PM2.5, < 2.5 μm) and ultrafine
(PM0.1, < 0.1 μm) particles. PM are found in multiple
physicochemical forms, due to environmental as well
as meteorological factors, and arise from diverse emis-
sion sources, both natural and anthropogenic [2, 4, 5].
Petroleum refineries, chemical plants and diesel engines
release combustion-derived PM into the atmosphere fol-
lowing incomplete combustion of volatile hydrocarbons.
The PM-rich soots produced during incomplete combus-
tion of fuels are complex and may contain, in addition to
polynuclear aromatic hydrocarbons (PAHs), a variety of
oxygen radical-generating quinones and metal species
[6–8]. PAHs, many of which are carcinogenic, are
present in combustion-derived PM and thereby may
increase considerably the potency of PM to induce
adverse health effects [9]. Combustion-derived PM,
particularly those resulting from traffic exhaust, are
known health risk factors and are responsible for
about 80 % of the human PM exposures [2]. Populations
living in urban communities near heavily traveled high-
ways potentially have a higher risk of exposure and conse-
quently, of diseases related to air pollution [10]. In 2012,
the World Health Organization estimated that outdoor air
pollution accounted for 3.7 million premature deaths
worldwide [11]. Thus, inhalation of outdoor air pollutants
remains a leading public health concern [11].
Extended, high PM exposures result in sharp increases
in morbidity and mortality. The Great London Smog of
1952 lasted 4 days, with peak particle concentrations
reaching 0.4 mg/m3, and resulted in an estimated 12,000
deaths [2, 12]. In 1991, five months after the start of the
fires at Kuwaiti oil depots and refineries, the concentra-
tion of ambient PM2.5 20 km from the fire site still
exceeded 830 μg/m3 [13]. In the 2001 World Trade Cen-
ter (WTC) attack, people were exposed to complex par-
ticle mixtures from the destroyed towers and the
burning aviation fuel. PM concentration levels remained
above 1 mg/m3 more than one week after the attack
[14]. Within a year of the WTC attack, a report on
aggravated morbidity and mortality among ‘first re-
sponders’ was published [15]. PM-exposed firefighters
also are a vulnerable sub-population of workers acutely
exposed to very high concentrations of dust, fumes and
gas mixtures. During the six days of the October 2003
Southern California wildfires, the maximum daily aver-
aged PM2.5 concentration was 270 μg/m
3 [16]. Further-
more, as in cases of pipeline sabotage, attacks on
refineries (Gulf War I), accidents at refineries/oil storage
depots (Texas City, TX, March 23rd 2005; Buncefield,
UK, December 13th 2005) and routine flaring of volatiles
at refineries, incomplete combustion of petrochemicals
results in production of large particle-rich soot clouds.
Although these sporadic events are considered to be
local, large segments of specific populations are subject
to these PM exposures. Thus, a variety of events result
in sub-acute and sub-chronic exposure to high levels of
airborne particles, with serious health problems detected
in large numbers of people exposed. These real-life
events are examples of acute and sub-acute exposures to
high concentrations of PM in humans, and highlight the
need to investigate the health effects induced by short-
term exposure to elevated levels of PM, as well as to as-
sess whether, and if so, how well these adverse effects
are resolved over time.
To take into consideration the latest epidemiological
and toxicological data, in 2012 the US EPA [17] revised
the standards for particle pollution and established the
annual mean particulate concentration at 50 and 12 μg/
m3 for PM10 and PM2.5, respectively. According to the
American Lung Association [18], nearly 15 % of all
Americans are exposed acutely to unhealthy levels of air-
borne pollutants (>35.0 μg/m3). Each year, 200,000 ex-
cess deaths in the US are attributable to PM [19].
Epidemiological data have shown that air pollution is as-
sociated with decreased lung function in both healthy
and susceptible populations of all ages [20–25]. It is now
well established that the ultrafine component of air pol-
lution causes adverse pulmonary effects through mecha-
nisms associated with inflammation and oxidative stress
[26–28]. Exposures to PM2.5 have been correlated with
increased cardiopulmonary and lung cancer mortality
[29, 30], as well as with increased risk of other respira-
tory and cardiovascular diseases [31–33]. Despite the
risks to human health, there is insufficient information
regarding the mechanisms underlying PM-mediated tox-
icity. Since many people are regularly exposed to PM,
there is a need to investigate the link between epidemi-
ology and biological plausibility by providing experimental
data related to the potential mechanisms of pulmonary in-
juries caused by PM.
Earlier studies on pulmonary responses to ultrafine
particle exposures in rodents [34–36] led us to investi-
gate respiratory responses to mildly extended inhalation
exposure to petrochemical combustion-derived ultrafine
particles. Butadiene soot (BDS), generated from the in-
complete combustion of 1,3-butadiene (BD), is both a
model of PM mixture and a real-life example of a petro-
chemical product of incomplete combustion (i.e., soot)
with the potential for environmental contamination and
for adverse effects to human health [37, 38]. In New Or-
leans (LA) in 1987, BD leaked from a tank car and
Noël et al. Particle and Fibre Toxicology  (2016) 13:10 Page 2 of 20
caught on fire. The tank car exploded and burned for
36 h. This resulted in the evacuation of thousands of
people living in proximity to the area where the incident
occurred. BD is carcinogenic and is listed among the
forty most produced chemicals in the United States. BD
is a high-volume, aliphatic hydrocarbon byproduct of
petroleum refining and is used in the manufacture of
synthetic rubber and other elastomers [39]. Similarly to
diesel exhaust particles, BDS is an organic-rich mixture
of inhalable fine and ultrafine (30–50 nm) carbonaceous
particles, organized as chain-like aggregates of primary
spherical particles, to which hundreds of PAH species,
including benzo(a)pyrene [B(a)P] and other carcinogens,
are adsorbed [2, 37, 38]. Inhalation of combustion-
derived PM pollutants, especially those with PAHs
adsorbed onto PM2.5 is a serious ongoing health concern
[3]. In this study, we investigated the respiratory effects
induced by BDS as an equivalent-alternative, relevant
and under-investigated source and component of PM2.5.
We reported previously that limited inhalation expo-
sures to BDS (5 mg/m3; 4 h/day, 4 days) leads to airway
neutrophilia and epithelial damage, and to accumulation
of particle-rich macrophages in airways of BDS-treated
mice [40]. Microarray and confirmatory qRT-PCR analyses
revealed sequential up-regulation of aryl-hydrocarbon re-
ceptor (Ahr) genes, oxidative stress response genes and
pro-inflammatory genes [40]. Following in vitro exposure
of a human bronchoepithelial cell line to BDS, we observed
sequential up-regulation of the same gene sets identified in
the in vivo exposures [41].
In this study, we hypothesized that moderately ex-
tended (21 days) inhalation exposures of mice to PM de-
rived from BDS generation will instigate a suite of
histopathologic and gene expression changes that will
resolve gradually. From an inhalation toxicology per-
spective, this study addresses two questions:
1. What are the consequences to the lungs of
moderately extended exposures (4 h/day, 21
consecutive days) to ultrafine particles derived from
petrochemical combustion?
2. How quickly do the lungs recover?
Results
Soot aerosols characterization
PAHs comprise 16–20 % of BDS particles by weight,
with pyrene, acepyrene, anthracene, and fluoranthene,
being the four predominant PAHs. Detailed physical and
chemical analyses of BDS were presented previously
[37, 38]. A scanning electron microscope image of
the aerosolized BDS particles is shown in Fig. 1a1.
The ultrafine BDS particles behave similarly to other
nanoparticles and aggregate into longer particles (Fig. 1a2).
Particle size distribution of the soot aerosols showed that
90 ± 4.1 % (Mean ± SD) of the particles present were in
the fine size range (PM2.5; Fig. 1b). Thus, the mice were
exposed to BDS aerosols composed of PAH-rich
nanoparticles.
Inflammatory responses and BDS retention in exposed
lungs are apparent
BALF cytology, BDS retention and lung histopathology
Lung responses of mice exposed to BDS particles
(5 mg/m3, 4 h/day, 21 consecutive days) mixed with
HEPA-filtered air were compared to lung responses of
HEPA-filtered air controls. Groups of mice were
sacrificed immediately after the 21-day exposures
ended (BDS 21d) and after 10 days of recovery (BDS
21d + 10d recovery). Differential 300-cell leukocyte
counts were performed on lung lavage samples from
6–8 mice/group. As expected, macrophages predomi-
nated in all the lavage samples (Fig. 2); however, in
the BDS 21d mice, the BALF differentials showed a
mild but significant (p < 0.05) elevation of the percentage
of neutrophils (6 % ± 0.95), compared with controls, which
were virtually neutrophil-free (0.13 % ± 0.08). Eosinophils
were not detected in any of the differential counts. Neu-
trophil differential values were significantly reduced
(0.67 % ± 0.37) in the BDS 21d + 10d recovery group com-
pared to the BDS 21d group, showing that the increase in
the percentage of neutrophils was consistent with a transi-
ent inflammatory reaction in the lungs (see below).
Lungs appeared grossly similar at both time points
(BDS 21d vs BDS 21d + 10d recovery). Soot-filled macro-
phages (red arrows) were prominent in the airways of
both groups of BDS-exposed mice, and the numbers of
soot-filled macrophages were not appreciably different
between the two BDS-exposed groups (Fig. 3a, b). Soot
particles (black arrows, Fig. 3a, b), not taken up by mac-
rophages, were present in the airways of both groups, as
well as immediately adjacent to airway epithelial cells. In
both groups of exposed mice, BDS particles were taken
up by airway cells. Inflammatory cells along the airways
(blue arrows, Fig. 3a, b) were present in both BDS-
exposed groups. Neither soot particles (macrophage-
bound or free) nor inflammatory cells were detected in
lungs of control mice (data not presented). Patterns of
soot particle deposition and retention in mouse lungs
were similar, both immediately after a 21-day continuous
exposure ended and after 10 days of recovery.
Histopathology evaluation of lung sections revealed
the presence of mild airway inflammatory responses im-
mediately following 21 days of BDS exposure that per-
sisted after 10 days of recovery (Fig. 4a, c, d). The
outcomes measured included mucosal, interstitial and
alveolar inflammation, presence of airway neutrophilia
and epithelial cell damage. Neutrophils were present in
mice in both BDS exposure groups (Fig. 4a). Despite the
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similarities in lung particle burden (Fig. 3a & b) and lung
neutrophilia (Fig. 4a) seen in BDS 21d and BDS 21d +
10d recovery mice, neutrophils were essentially absent
from BALF after 10 days recovery (Fig. 2). Among all
the tissue outcomes, only epithelial damage was reduced
in the 10-day recovery samples (Fig. 4b). Thus, soot par-
ticles were not cleared from the lungs (Fig. 3b), and in-
flammatory cells were still present in the lungs (Fig. 4a),
10 days after inhalation of soot particles had ended.
Control airways had no detectable particles and showed
no evidence of inflammation (Fig. 4a, c, d).
Inflammation markers in BALF were analyzed to assess
levels of airway inflammation following a 3-week exposure
to BDS ultrafine particles. Out of the 7 pro-inflammatory
cytokines analyzed, only KC and IL-1β had levels above
the limit of detection. The 3-week exposure to BDS in-
duced a significant increase in IL-1β compared to air
exposures or BDS 21d + 10d recovery (Fig. 5). Therefore, a
pro-inflammation airway cytokine response marked by
IL-1β was detected in BALF (Fig. 5) concurrent with
the inflammatory reaction observed in the lungs of
BDS-exposed mice but not BDS-exposed mice allowed
10 days of recovery (Figs. 2 and 4a, c, d).
BDS-associated changes in gene expression are detected
even 10 days after exposures end
Microarray
Principal component analysis of the microarray data
revealed distinct clustering by treatment group, with
greater variation between groups than within groups.
This validated the subsequent intergroup comparisons.
Next, microarray results were examined to determine
whether genes were differentially expressed in either
BDS group vs. controls. After Expression Analysis filtering
Fig. 1 The combustion-derived BDS particle aerosols are composed mainly of PAH-rich (pyrene, acepyrene, anthracene and fluoranthene) fine
sized (< PM2.5) agglomerated particles, (a) Electron microscopy images 1- scanning electron microscopy and 2- transmission electron microscopy)
of BDS showing spherical, uniformly sized (20–40 nm diameter) primary particles, that have bundled into branches, chain-like shaped agglomerates
that can reach the micrometer size range. b Particle size distributions of the aerosols show that > 90 % of the particles present are in the fine size range
(PM2.5), and are composed of agglomerated individual ultrafine (<100 nm) particles [38]
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of the microarray data (fold change ≥ 1.5, FDR and tran-
script p-value each < 0.05) and removing duplicate, poorly
characterized and unmapped transcripts, 102 unique tran-
scripts (all up-regulated) remained that were differentially-
expressed in lungs of BDS 21d mice vs. lungs of control
mice. Three distinct groups of genes - biotransformation,
oxidative stress, inflammation (Table 1) - were apparent
from among the 102 unique up-regulated transcripts
(BDS 21d vs. control) that passed all the selection criteria.
Up-regulated Phase I biotransformation genes included
Cyp1a1 (18.32 fold) and Cyp1b1 (25.83 fold); aryl hydro-
carbon receptor repressor, Ahrr (3.56 fold) and Aldh3a1
(7.97 fold). Up-regulated oxidative stress response genes
included, Nqo1 (4.16 fold); glutathione peroxidase 2, Gpx2
(1.97 fold), and carboxylesterase 1 (3.88 fold). Inflamma-
tory/immune response genes included chemokine (C-X-C
motif) ligand 2, Cxcl2 (2.33 fold), Cxcl5, the mouse homo-
log of the human chemokine Cxcl6 (4.43 fold); Ccl20 (3.60
fold); Ccl28 (1.96 fold); a disintegrin and metallopeptidase,
domain 8, Adam8 (3.13 fold); Vanin 1 (3.30 fold);
prostaglandin-endoperoxide synthase 2, Ptgs2 (2.05) and
the acute phase proteins, ceruloplasmin, Cp (1.82); com-
plement factor B, Cfb (2.61); orosomucoid 1, Orm1 (4.73
fold); and serum amyloid a3, Saa3 (7.86-fold). Thus,
microarray analysis reveals that 3 weeks of daily inhalation
exposure to BDS particles results in up-regulation of bio-
transformation, oxidative response, and inflammatory
genes (Fig. 6).
Ten days after BDS exposures ended, many of the
genes that were up-regulated in lungs of BDS 21d mice
(above) remained significantly elevated although the ab-
solute levels of expression were reduced (Table 2). Phase
I and phase II biotransformation genes in this group in-
cluded Ahrr (2.14 fold), Cyp1b1 (2.60 fold), and Aldh3a1
(1.72 fold); the inflammatory/immune response genes Il-
6 (2.08 fold), Adam8 (1.82 fold) and Ptgs2 (1.85 fold);
and the acute phase proteins Saa1 (1.69 fold), Orm2
(2.17 fold) and Cfd (3.53 fold). Thus, even 10 days after
BDS exposures end, biotransformation, oxidative stress
and inflammation-related genes remain significantly high
(vs. controls) in the lungs of BDS-exposed mice (Table 2).
qRT-PCR
Figure 7 shows results obtained by qRT-PCR that were
used to a) confirm up-regulation of 4 biotransformation
(Ahrr, Aldh3a1, Cyp1a1 and Cyp1b1), 6 oxidative stress
(Gclc, Gpx2, Hmox1, Nfe2l2, Nqo1, Txnrd1) and 8 in-
flammation genes (Ccr7, Cxcl2, Cxcl5, Il6, Ptgs2, Lcn2,
Orm2, Saa1) in BDS 21d vs control mice and b) deter-
mine whether those genes remained up-regulated (vs.
controls) in BDS 21d + 10d recovery mice. These data
confirmed the array results.
Western blotting
Figure 8 demonstrates that protein expression confirmed
qRT-PCR and gene expression results, showing that
Fig. 2 21 days exposure to BDS significantly increased the percentage of neutrophils (6 % ± 0.95) in BALF; following the 10-day recovery period,
the percentage of neutrophils decreased to just above pre-exposure levels (0.67 % ± 0.37). No eosinophils were observed. Data represent the
mean ± the standard error of the mean (SEM) for n = 6–8 mice per group. ANOVA followed by a Tukey’s test, p < 0.05: ** BDS 21d statistically
different from all other groups
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ALDH3A1, CYP1A1, CYP1B1, and NQO1 were up-
regulated in BALB/c mice exposed to 5 mg/m3 of BDS
4 h/day for 4 days. Table 3 compares the RNA expres-
sion levels of the 4 genes at 4 and 21 days, as well as at
21 days + 10 days recovery that were subsequently ana-
lyzed by Western blotting for the 5 mg/m3 for 4 days ex-
posure group.
Pathway analysis
Figure 9 presents a network created in the Ingenuity sys-
tem illustrating the interaction of gene pathways in BDS
21d vs. control mice. The three sets of up-regulated
genes identified above - biotransformation, oxidative re-
sponse and inflammatory/immune - were identified as
being differentially expressed and inter-related within
specific gene pathways.
Discussion
Long-term health consequences of involuntary exposure
to petrochemical-derived soot particles have received
insufficient attention. Populations living in close proxim-
ity to heavy road traffic areas, people exposed to re-
finery, fuel depot and pipeline explosions/fires and even
those routinely exposed to refinery flares might be ex-
pected to carry a PAH-enriched lung particle burden
that would persist after exposures end and activate PAH-
metabolism pathways, causing up-regulation of oxidative
stress and inflammatory pathways, resulting in histopatho-
logical changes to the lungs. In the absence of future ex-
posures, these changes ultimately may be resolved.
However, in infants and young children or in individuals
with impaired lung function due to chronic diseases (e.g.,
asthma or COPD) or respiratory infections, symptoms or
illness could be aggravated as a result of these additional
and largely unavoidable PM exposures. Adverse respira-
tory effects in healthy and susceptible populations of all
ages have been reported at PM exposure levels at or below
ambient air quality health standards [42, 43]. The experi-
ments described here were designed to assess a) the histo-
pathologic and transcriptome changes associated with an
Fig. 3 All mice from exposed groups had intracellular BDS. Mice were sacrificed immediately after the last exposure ended (a and c) or after
10 days of recovery (b and d). Red arrows = BDS-filled macrophages; blue arrows = inflammatory cells; black arrows = intracellular BDS; AM= alveolar
macrophage containing phagocytized BDS; I = interstitial inflammatory cells; *I = BDS in interstitial inflammatory cell; IE = intraepithelial BDS; S = BDS
apposed or adhered to mucosal surface
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Fig. 4 Pathology evaluation of the lungs confirms that the mild neutrophilic inflammation is caused by 21 days of exposure to BDS. a, c, d
specific type of inflammation present in the lungs; (b) epithelial damage observed in the lungs. 5–8 mice per group. Scoring: 0 = none; 1 =mild;
2 =moderate; 3 = severe
Fig. 5 21 days of exposure to BDS significantly increased the BALF concentrations of IL-1β. Data represent the mean ± the standard error of the
mean (SEM) for n = six mice per group. ANOVA followed by the Holm-Sidak method for all pairwise multiple comparisons, p < 0.05: *BDS
21d statistically different from all other groups
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extended (21 consecutive days) exposure to PAH-rich
soots and b) determine how well the changes resolve over
time. The 5 mg/m3 concentration that was selected for
this study is of the same order of magnitude as the levels
measured more than one week after the World Trade
Center attack (1 mg/m3) [14] and five months after the
Kuwaiti oil fires of 1991 (830 μg/m3) [13].
The BDS aerosols produced in the present study were
PM mixtures composed of nanoparticles that aggregated
into coarse and fine particles of respirable size (Fig. 1).
BDS or petrochemical soots generally cause respiratory
effects similar to those caused by other types of air pol-
lutants, such as diesel exhaust particles (DEP) or residual
oil fly ash (ROFA), mainly through mechanisms associ-
ated with inflammation and oxidative stress [40, 44–47].
Despite similarities with DEP and ROFA for particle
sizes and PAH distribution, BDS is relatively low in oxy-
gen and metals content [38]. Since numerous studies
[48–52] have associated the PAH content adsorbed onto
PMs as a key contributor to PM-induced adverse health
effects, including childhood asthma [51] and systemic
inflammation [53], the concentration of PAHs, particu-
larly pyrene, acepyrene, anthracene and fluoranthene on
the PM in the present study are implicated in the ob-
served activation of PAH-metabolism pathways [38]
(Figs. 6, 7, 8 and 9). These results show that conducting
Table 1 Function-related clusters of differentially expressed genes for 21d BDS mice sacrificed immediately after the last exposure
ended vs. air controls (fold change > 2 and FDR p-value < 0.05)
Gene symbol Gene descriptor Raw estimated fold change BDS 21d vs air control
Inflammation cluster
Saa3 serum amyloid A 3 7.86
Cxcl1 chemokine (C-X-C motif) ligand 1 5.42
Reg3g regenerating islet-derived 3 gamma 4.75
Orm1 orosomucoid 1 4.73
Cxcl5 chemokine (C-X-C motif) ligand 5 4.43
Ccl20 chemokine (C-C motif) ligand 20 3.60
Vnn1 vanin 1 3.30
Adam8 a disintegrin and metallopeptidase domain 8 3.13
Cfb complement factor B 2.61
Cxcl2 chemokine (C-X-C motif) ligand 2 2.33
Cd14 CD14 antigen 2.07
Ptgs2 prostaglandin-endoperoxide synthase 2 2.06
Ccl28 chemokine (C-C motif) ligand 28 1.96
Biotransformation cluster
Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 25.83
Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 18.32
Aldh3a1 aldehyde dehydrogenase family 3, subfamily A1 7.97
Ahrr aryl-hydrocarbon receptor repressor 3.56
Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide 3.35
Scgb3a1 secretoglobin, family 3A, member 1 3.21
Ltf lactotransferrin 2.50
Afp alpha fetoprotein 2.31
Steap4 STEAP family member 4 2.07
Itih4 inter alpha-trypsin inhibitor, heavy chain 4 2.02
Oxidative stress cluster
Nqo1 NAD(P)H dehydrogenase, quinone 1 4.16
Ces1 carboxylesterase 1 3.88
Akr1b8 aldo-keto reductase family 1, member B8 2.02
Acox2 acyl-Coenzyme A oxidase 2, branched chain 2.01
Gpx2 Glutathione peroxidase 2 1.97
Noël et al. Particle and Fibre Toxicology  (2016) 13:10 Page 8 of 20
both physical and chemical characterization of the aero-
sol is essential to adequately correlate the lung responses
to the airborne PM mixtures used.
Since inhalation is the main portal of entry for PMs,
the fate and toxicity of these particles are dictated by the
lungs’ deposition and clearance mechanisms [54]. Effect-
ive elimination of particles deposited in the lungs is
largely accomplished by alveolar macrophages and by
mucociliary clearance [55–57]. Limited translocation
however, of fine and ultrafine insoluble particles from
the lungs to extra-pulmonary organs, such as the heart,
has been reported [58–60]. In the present study, although
extra-pulmonary translocation may have ensued, the lung
responses and recovery following sub-acute exposures to
BDS were the focus and extra-pulmonary translocation
was not investigated.
Recently, macrophages filled with carbon particles
have been investigated as a potential novel biomarker of
combustion-derived PM exposures in humans [61]. That
systematic review showed that for exposures to
combustion-derived PM10, ranging from 20 – 30 μg/m
3,
carbon load in macrophages reflected cumulative expos-
ure and was appropriate for personal exposure estimates.
A study conducted in children found that the median
area of black material (i.e. carbon) in alveolar macro-
phages could serve as a biomarker of past low PM10
exposures ranging between 0.15 and 2.5 μg/m3 [62].
Although in our study we used BDS as a surrogate for
PM2.5, approximately 3.2 % of the aerosols were com-
posed of PM10 (Fig. 1b). It is unknown whether the BDS
we observed in lung macrophages 10 days post-exposure
were filled with large, i.e. 10 μm, or smaller, i.e. 2.5 μm
particles; however, since the majority of the aerosols
were composed of PM2.5, our data are supportive of fu-
ture research in animals or in humans on macrophage
carbon load as a potential sensitive biomarker for short
and long-term exposures to combustion-derived PM2.5.
Further in vivo work should quantify the particles, i.e.
carbon, metals and PAH content in the collected macro-
phages and lung tissue to associate a quantitative value to
this biomarker. Furthermore, while BDS-filled macro-
phages were observed in the lungs 10 days post-exposure,
our results also show that alveolar phagocytosis and
mucociliairy clearance were not completely effective in
the removal of particles at this time point (Fig. 3b). The
presence of PM in lung parenchymal cells and macro-
phages at 10 days after exposure ends is not an unusual
adverse effect, given the clearance half-time of poorly-
soluble particles in the lungs of mice. Indeed, Bermudez et
al. [63] showed that the clearance half-time was 40 days
for mouse lungs exposed for 13 weeks to 2 mg/m3 of
ultrafine TiO2 particles. Nonetheless, the potential health
Fig. 6 21 days exposure to BDS significantly increased the expression of several inflammation, cytokine, biotransformation and oxidation reduction-
related genes relative to controls. Microarray results are presented for global gene expression of left lung (see methods for details regarding the gene
expression analysis). Data are expressed as BDS 21d compared to controls (log2 ratio fold increases) for selected genes (n= four mice per group)
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risk caused by PM exposures has been associated with
persistent particle load in macrophages, inducing subse-
quent long-term damage in the lungs through irritation
and inflammation mechanisms [5, 40]. In addition, we ob-
served the presence of soot particles in the airways, adja-
cent to epithelial cells (Fig. 3), that were not taken up by
macrophages even at 10 days post-exposure. This effect
shows that the first steps in the alveolar-macrophage me-
diated clearance, i.e., the detection and recognition of the
deposited particles by the alveolar macrophages, is incom-
plete at 10 days post-exposure. Numerous studies have
noted that the phagocytic activity of alveolar macrophages
is optimal for particles larger than 500 nm and less effect-
ive for particles in the ultrafine (<100 nm) range [34, 36,
58, 60, 64, 65]. It is thought that given their small size, ul-
trafine particles do not produce signals strong enough to
stimulate macrophage chemotaxis towards their target
[66–68]. Thus, our data show that even though the overall
acute lung responses to BDS inhalation were modest, the
potential exists for long-term effects through persistent
particle load and free particle interaction with the airways.
IL-1β is an acute phase cytokine associated with
macrophage activation and inflammation [69–71]. In
addition, activated macrophages can release numerous
other inflammatory mediators which attract other im-
mune cells, such as neutrophils, to the site of the injury
[69–71]. Figure 2 shows that the percentage of neutro-
phils in BALF was significantly increased in the BDS 21d
group compared to the respective air control and BDS
21d + 10d recovery groups, suggesting that the overall
inflammatory reaction process was initiated during expos-
ure, but returned to baseline values after the exposure
ended. Up-regulation of the IL-1β gene has previously
been reported in both in vitro and in vivo studies of PM
associated with PAHs [40, 50, 52]. We have previously re-
ported that levels of IL-1β were significantly increased in
Table 2 Selected differentially expressed genes for BDS 21d + 10d recovery vs. air controls (fold change > 1.5 and 2 and FDR p-value < 0.05)
Gene symbol Gene descriptor Raw estimated fold change BDS 21d + 10d R vs air control
Saa1 serum amyloid A 1 1.69
Aldh3a1 aldehyde dehydrogenase family 3, subfamily A1 1.72
Adam8 a desintegrin and metallopeptidase domain 8 1.82
Ptgs2 prostaglandine-endoperoxide synthase 2 1.85
Clec4g C-type lectin domain family 4, member G 2.01
Dnai2 dynein, axonemal, intermediate chain 2 2.03
Retn resistin 2.06
Il-6 interleukin 6 2.08
Ahrr aryl-hydrocarbon receptor repressor 2.14
Tmem45b transmembrane protein 45B 2.15
Dmrt2 doublesex and mab-3 related transcription factor 2 2.17
Orm2 orosomucoid 2 2.17
Cidea cell death-inducing DFFA-like effector a 2.20
Cxcr6 chemokine (C-X-C motif) receptor 6 2.22
Prmt8 protein arginine methyltransferase 8 2.29
Cyr61 cysteine-rich, angiogenic inducer, 61 2.40
Slc6a20 solute carrier family 6 (proline IMINO transporter), member 20 2.41
Sult1d1 sulfotransferase family 1D, member 1 2.48
Fabp4 fatty acid binding protein 4, adipocyte 2.51
Ighm immunoglobulin heavy constant mu 2.56
Cyp1b1 cytochrome P450, family 1, subfamily B, polypeptide 1 2.60
Fabp4 fatty acid binding protein 4, adipocyte 2.89
Sult1d1 sulfotransferase family 1D, member 1 3.07
Thrsp thyroid hormone responsive 3.13
Cfd complement factor D (adipsin) 3.53
Adipoq adiponectin, C1Q and collagen domain containing 3.77
Plunc palate, lung and nasal epithelium associated 4.58
Ca3 carbonic anhydrase III, muscle specific 4.84
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BALF of mice exposed to 5 mg/m3 of BDS for 4 days vs.
air-control mice [40]. In the present study, since IL-1β
was significantly elevated in the BALF of mice exposed to
BDS for 21 days (Fig. 5), this result suggests that the sub-
acute inhalation exposure to combustion-derived particles
caused an inflammatory reaction in the lungs (Figs. 2 &
4). Hence, even though the lung inflammatory response
seemed modest after 21 days of exposure to BDS, our
data, with increased levels of IL-1β in BALF, indicate local
airway damage.
Based on the histopathology score, mucosal inflamma-
tion was the most severe lung response to 21 days of ex-
posure to BDS (Fig. 4c). Recovery, however, was observed
10 days post-exposure for mucosal inflammation and
Fig. 7 qRT-PCR results confirm that 21 days exposure to BDS significantly increases the expression of several biotransformation, oxidative stress,
inflammation and acute phase reactant- related genes. The 10 day recovery period allows a significant decrease in those gene expression levels.
Data represent the mean for n = 5–7 mice per group. UNIVARIATE and TTEST procedures, p < 0.05: ** BDS 21d statistically different from respective
controls and BDS 21d + 10d recovery. *BDS 21d or BDS 21d + 10d recovery statistically different from respective controls
Fig. 8 Protein expression: (a) Western blots confirmed that ALDH3A1, CYP1A1, CYP1B1, and NQO1 were up-regulated in Balb/c mice exposed to
5 mg/m3 of BDS 4 h/day for 4 days. 5 mg/m3 BDS treatment vs. controls. b Mean densitometry ± SEM results showing fold increases of treated
mice vs. controls for the four proteins analyzed
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epithelial damage, but not for neutrophilic and interstitial
inflammation (Fig. 4). This shows that different regions
within the lung repair at different rates, with inflammation
located in the mucus membranes resolving faster than
inflammation located in the connective tissues. Thus, one
conclusion from this study is that mice are capable of re-
covering from mucosal inflammation. Total lung recovery,
if it occurs, probably requires a longer period than 10 days
in mice. According to an epidemiology study on WTC-
exposed firefighters who were present at ground-zero
starting immediately after the attack, only 36.4 % had
recovered from lower-respiratory symptoms, including
cough, dyspnea and wheeze, 7 to 9 years after the attack
[72]. This study in humans showed that after acute
exposures to high concentrations of PM, resolution of
low-respiratory symptoms was possible for a moderate
percentage of the cohort. The BDS results presented
here suggest that lung mucosal inflammation recovery
is one of the first pulmonary injuries to resolve.
It is well known that conducting gene expression ana-
lysis on collected tissues provides a specific time window
on changes occurring at the RNA and corresponding
protein levels [52]. These temporal changes can evolve
quickly and thus, assessing gene expression analysis at
more than one time point is crucial for obtaining a glo-
bal picture of the processes [52]. In the present study,
gene expression analysis was performed at two time
points, immediately after the 21-day exposure ended and
following a recovery period of 10 days. For selected pro-
teins, levels were quantified after 4 days of exposure.
This allowed evaluation of the time-course and extent of
pulmonary recovery following a sub-acute exposure to
5 mg/m3 of BDS.
Among the genes up-regulated in the 21-day BDS
group (Table 1, Fig. 6) were Cxcl1 (5.42 fold), CxCl2
(2.33 fold) and Cxcl5 (4.43 fold), which are all involved
in neutrophil chemotaxis [69–71, 73]. Up-regulation of
these 3 genes in the 21-day BDS group supports the
BALF differential (Fig. 2) and the histopathology results
(Fig. 4A) which highlight the presence of neutrophils in
Table 3 Time-course of up-regulation of selected genes following
inhalation of BDS
Gene 4 days BDS 21 days BDS 21 days + 10 days recovery
Aldh3a1 2.43 8.63 1.76
Cyp1a1 41.93 22.32 2.14
Cyp1b1 30.71 33.10 2.83
Nqo1 3.60 7.92 2.16
Data quantified by qRT-PCR are expressed as fold increase compared to their
respective control groups
Fig. 9 BDS inhalation/exposure (for 3 weeks, with or without 10 days of recovery) predominantly activates/up-regulates genes associated with
xenobiotic metabolism, aryl hydrocarbon receptor activity, Nrf2-mediated oxidative stress responses and IL-17A signaling in airway cells, according
to Ingenuity Pathway Analysis
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lungs of the 21-day BDS group. This same set of genes
was also up-regulated to a similar extent in the lungs of
mice exposed to BDS for 4 days [40], but not in lungs of
the 21-day BDS + 10 days of recovery group (Table 2;
Figs. 2 and 7). These results indicate that the pulmonary
inflammatory responses are acute reactions to soot
nanoparticles and suggest that the soot components
responsible for eliciting the lung inflammatory responses
are labile.
In addition to inflammation-related genes, 21 days of
exposure to BDS significantly elevated the gene expres-
sion levels of Ahrr (3.56 fold), Nqo1 (4.16 fold), Aldh3a1
(7.97 fold), Cyp1a1 (18.32 fold) and Cyp1b1 (25.83 fold),
all of which are related to biotransformation and oxidative
stress (Table 1, Fig. 6). Ten days after BDS exposures
ended, many of the genes that were up-regulated in lungs
of BDS 21d mice (above) remained up-regulated although
the absolute levels of expression were reduced signifi-
cantly, up to 90 % (Table 2; Fig. 7). Phase I biotransform-
ation genes in this group included Ahrr (2.14 fold) and
Cyp1b1 (2.60 fold); the inflammatory/immune response
genes Il-6 (2.08 fold) and Cxcr6 (2.22 fold); and the acute
phase proteins Orm2 (2.17 fold) and Saa1 (1.69 fold). In
the lungs, PAH metabolism and detoxification pathways
usually process through the cytochrome p450 systems,
particularly the isoforms Cyp1a1, and Cyp1b1 [52]. Both
of these isoforms are of interest since via activation of the
aryl hydrocarbon receptor (Ahr) they metabolize PAHs
from PM, which can lead to bio-activation of metabolites
[49, 52, 74–76]. Supporting our results are previous stud-
ies conducted in mice exposed to various types of PM that
have reported increased gene expression of Cyp1a1 and
Cyp1b1 in the lungs [40, 52, 77, 78]. In our study, even
10 days after BDS exposures ended, 6 core BDS genes
(Ahrr, Cyp1a1, Cyp1b1, Nqo1, Il-6, Ptgs2) related to
biotransformation, oxidative stress and inflammation
remained up-regulated in the lungs of BDS-exposed
mice (Fig. 7). Also, following 21 days of exposure to
BDS, the expression of phase I biotransformation
genes (Cyp1a1 and Cyp1b1) was much higher (>22
fold increase) than the expression of phase II bio-
transformation genes (Aldh3a1 and Nqo1) (8 to 9 fold
increase; Table 3). However, after a 10-day recovery
period, the expression of these phase I and II bio-
transformation genes returned to similar levels of ex-
pression (≈2 fold increase) that were still significantly
increased compared to controls (Table 3, Fig. 7).
These results indicate that the elevated expression of
phase I biotransformation genes is an acute response
to soot nanoparticles, and that 10 days after exposure
has ended, phases I and II of biotransformation might
still be occurring in the lung.
Xenobiotic metabolism and aryl hydrocarbon receptor
pathways have been related to PAH biotransformation
and elimination processes, both in in vitro and in vivo
studies [40, 41, 52, 74, 75, 77, 78], while oxidative stress
and inflammation pathways have mostly been associated
with ultrafine particle – cell interactions [79–89]. The
latter studies, which used inert ultrafine particles, with-
out any PAH content, such as carbon black and titanium
dioxide, showed significant increases in inflammation
and oxidative stress in vitro and in vivo. These studies
therefore suggest that the baseline physical effects (in-
flammation and oxidative stress) induced by inert ultra-
fine particles in the lungs might be related to the
persistent physical presence of the particles [5, 40]. Our
gene expression results are supported by the Ingenuity
Pathways Analysis, which revealed the relationships con-
necting the 4 different networks of up-regulated genes,
i.e. xenobiotic metabolism, aryl hydrocarbon receptor,
Nrf2-mediated oxidative stress responses and IL-17a sig-
naling in airway cells (Fig. 9). These networks link the
BDS physicochemical characterization: a) its PAH con-
tent [38], to xenobiotic metabolism and Ahr pathways
(Table 1, Figs. 6, 7, 8 and 9) and b) the physical presence
and size distribution of the BDS aerosols (Fig. 1) [37, 38],
to oxidative stress-related responses and inflammation sig-
naling pathways (Table 1, Figs. 2, 3, 4, 5, 6, 7, 8 and 9).
Similar networks also were identified in our previous
study where mice were exposed to BDS for 4 days [40].
Taken together, these data on responses to inhaled
aerosolized BDS indicate that at least two distinct but co-
operating processes underlie the lung responses to PAHs
adsorbed onto ultrafine particles.
Quantitative qRT-PCR were carried out to confirm the
microarray gene expression results from BDS 4 days,
BDS 21 days and BDS 21 days + 10 days recovery mice
for selected genes, including the attenuated, but still sig-
nificantly elevated, values in the BDS 21d + 10d recovery
group vs. those in BDS 21d group (Figs. 7 and 8). In
most cases, the expression fold changes via PCR
exceeded the equivalent microarray values. A total of 18
genes were confirmed by PCR. A comparison of the
gene expression levels for exposure periods of 4, 21 and
21 days + 10 days recovery is shown in Table 3. Cyp1a1
gene expression level decreased somewhat, but remained
significantly elevated, from 4 to 21 days of exposure
(Table 3) This result suggests an adaptive response for
this biotransformation gene. Protein expression of bio-
transformation related genes, ALDH3A1, CYP1A1,
CYP1B1 and the oxidative stress related gene NQO1
were increased in mice exposed to 5 mg/m3 of BDS for
4 days compared to their respective filtered-air controls
(Fig. 8). Correspondingly, the gene expression fold
changes measured by qRT-PCR were up-regulated by
more than 2.4-fold compared to the controls in both the
4-and 21-day BDS exposure groups (Table 3). In
addition, the gene expression fold changes were higher
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for Cyp1b1 than for Cyp1a1 after 21 days of exposure
(Table 3). Similar results comparing protein expression
of CYP1A1 and CYP1B1 following PM exposures have
been reported previously [74, 75]. In a study conducted
by Iba et al. [75] CYP1A1 and CYP1B1 activities, related
to their catalytic and induction properties, were assessed
ex vivo in human lung samples. Analysis of these en-
zymes by western blot showed that benzo[a]pyrene
(B[a]P) and diesel exhaust extract induced CYP1A1, but
not CYP1B1. In another study, Courter et al. [74] re-
ported that in mouse epidermis exposed to urban dust
particulate matter, B[a]P and dibenzo[a,l]pyrene, that
CYP1A1 protein expression was increased following in-
dividual exposures to all three substances and to co-
treatment exposures, while CYP1B1 protein was not
expressed in even one of the co-treatment groups. The
Ah receptor regulates the expression of these two en-
zymes, and our results, as well as others from the litera-
ture, point out that, at least at the protein level, CYP1A1
seems to be more sensitive to changes induced by PAHs
adsorbed onto PM than is CYP1B1. Overall, our micro-
array, qRT-PCR and western blotting results support the
conclusion that 21 days of exposure to BDS induces a
transient, time-dependent up-regulation of Ahr, biotrans-
formation and oxidative stress related genes. Another
study has also shown that changes in gene expression
were transient and suggested lung recovery in mice fol-
lowing exposures to approximately 94 μg/m3 of urban air
pollution [90]. In that study, a 3-week exposure resulted
in changes reflected through 70 differentially-expressed
genes compared to HEPA-filtered air control mice, while
6 weeks after a 10-week exposure to those same particles
had ended, the number of differently expressed genes,
which were associated with metabolism pathways, de-
creased to 13. Thus, that study and ours suggest that the
genes that are persistently altered following a recovery
period could be the ones responsible for the long-term
lung effects induced by combustion-derived particles.
In our study, the genes that were still significantly
up-regulated after 10 days of recovery included Ahrr,
Cyp1a1, Cyp1b1, Nqo1, Il-6 and Ptgs2 (Fig. 7). Further
studies should investigate the specific role(s) of these
genes in chronic cardio-respiratory diseases induced
by PM exposures.
Previously we reported that PAHs adsorbed onto the
surface of BDS are transferred to the plasma membrane
of human bronchoepithelial cells (BEAS-2B) and subse-
quently to the cell interior [38]. We also reported that
the PAHs were accumulated / stored within lipid drop-
lets of these cells, and that the PAHs were able to acti-
vate xenobiotic metabolism pathways via the smooth
endoplasmic reticulum, as evidenced by up-regulation of
Cyp1a1, Cyp1b1, and Aldh3a1 [41]. Furthermore, mice
exposed to 5 mg/m3 of BDS for 4 days exhibited airway
inflammation; neutrophilia, bronchial and epithelial
damage; as well as particle accumulation in alveolar
macrophages, accompanied by up-regulation of bio-
transformation, oxidative stress and pro-inflammatory
genes [40]. In the current study, we show that 21 days of
exposure of mice to 5 mg/m3 of BDS induced results
similar to those in our 4-day exposure study [40]. In
addition, we report that a recovery period of 10 days,
following 21 days of exposure, is insufficient to reduce
1) lung connective tissue inflammation, 2) particle alveolar
load, and 3) expression of multiple biotransformation, in-
flammation and oxidative stress-related genes, to baseline
levels. Thus, building upon our previous work, both in
vitro and in vivo, on health effects induced by BDS aero-
sols [37, 38, 40, 41], we hypothesize that these PM health
effects are associated with a “double hit” mechanism,
whereby the PAHs’ chemical effect is added to the physical
BDS nanoparticle effect. First, PAHs, mostly pyrene, ace-
pyrene, anthracene, and fluoranthene, adsorbed onto the
BDS particles, are transferred to the lung cells and localize
within lipid droplets, initiating the up-regulation of phase
I (Cyp1a1 and Cyp1b1) and later phase II (Aldh3a1 and
Nqo1) biotransformation genes (Tables 1, 2 and Fig. 9; [37,
38, 41]). The accumulation and storage of these chemicals
in lipid droplets prolong the activation of biotransform-
ation genes, as evidenced by significant up-regulation of
these genes even 10 days post-exposure (Fig. 7; [41]). Fur-
thermore, the physical presence of free BDS particles in
the lung parenchyma, both immediately after exposures
end, as well as 10 days post-exposure, added to persistent
particle-laden macrophages (Fig. 3; [40]), produces, via
the normal particle elimination processes, oxidative stress
(Nfr2-related responses), as well as mild and transient in-
flammatory reactions (IL-17a signaling; Figs. 2, 4 and 9;
[40]). As mentioned previously, the damage produced by
the chemical and physical components of the BDS share
common toxicity pathways. Most importantly, we believe
it is the storage of PAHs in lipid droplets, which could ex-
tend their presence in the organism well beyond the initial
removal of particles by alveolar macrophages from the
lungs, that facilitates persistent changes in gene expres-
sion, and may contribute to long-term lung or systemic ef-
fects induced by BDS. Hence, the incomplete lung
recovery following sub-acute inhalation exposures to
PAH-rich PM2.5 may thereby also promote a pro-Ahr acti-
vated, pro-oxidant, and pro-inflammatory milieu in the
lungs, which may aggravate prior existing conditions or
sensitize this environment to the development of cardio-
respiratory diseases, including lung cancer and
atherosclerosis.
Conclusion
In summary, we have shown that sub-acute exposures of
mice to fine particles rich in PAHs induced: (1) BALF
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neutrophilic inflammation; (2) lung mucosal inflamma-
tion, and (3) increased BALF IL-1β concentration; with
all three outcomes returning to baseline levels 10 days
post-exposure. In addition, (4) lung connective tissue in-
flammation persisted 10 days post-exposure; (5) time-
dependent up-regulation of Ahr-biotransformation and
oxidative stress genes was detected; and (6) persistent
particle alveolar load following 10 days of recovery was
observed. Thus, our data show that even though the
overall sub-acute lung responses were modest, incom-
plete lung recovery may be a starting point for potential
long-term cardio-pulmonary effects. More research is
needed to understand the cardio-pulmonary impact of
persistent lung gene expression changes after a recovery




Six-week old female BALB/c mice were obtained from
Jackson Laboratories (Bar Harbor, ME). After a one-week
acclimation period, animals were housed individually in
suspended steel wire cages at the AAALAC-accredited In-
halation Research Facility at Louisiana State University.
The mice were handled in accordance with the NIH Guide
for the Care and Use of Laboratory Animals; and all proce-
dures were approved by the Louisiana State University In-
stitutional Animal Care and Use Committee. Food and
water were provided ad libitum between exposures, but
were removed during the daily exposures to prevent their
contamination with particles and/or chemical residues.
BDS generation and exposures
BDS was generated as described previously [38]. Briefly,
BDS generation took place in a 0.25 m3 stainless steel
and plexiglass chamber that was connected to an adja-
cent stainless steel and plexiglass 0.25 m3 inhalation
chamber in which the animals were exposed to BDS.
The BDS was drawn from the generation chamber to
the exposure chamber by a static pressure differential.
HEPA-filtered air was used to maintain steady-state tar-
geted BDS particle concentrations between 5.0–6.5 mg/m3
in the exposure chamber. The 10-day exposure yielded a
mean mass concentration and a standard deviation of 6.08
± 3.0 mg/m3. This concentration was selected to address
the knowledge gap on health effects induced by short-term
exposure to elevated levels of PM in humans, that are rep-
resentative of real life events, including wildfires, pipeline
sabotage and accidents at refineries. HEPA-filtered airflow
rates in control and exposure chambers were maintained
at approximately 140 L/min. Particle concentration in the
exposure chamber was monitored in real-time with a Dust-
Trak (Model 8520; TSI Inc., St. Paul, MN); this concentra-
tion was confirmed by gravimetric filter comparison. Both
the DustTrak probe and the filter holder were positioned
in the airflow immediately above the cages housing the
mice. For the size distribution, as described in [38], parti-
cles were collected and size-fractionated by a three-stage
(<2.5 μm; 2.5–10 μm and > 10 μm) RespiCon virtual sam-
pler. Detailed descriptions of the soot aerosols particle size
distribution, PAH and metals content of BDS have been
presented previously [37, 38].
In the first part of the experiment, six eight-week old
female mice inhaled BDS mixed with HEPA-filtered air
(4 h/day, 21 consecutive days), while six female controls
were exposed only to HEPA-filtered air for the same
time. All mice in each group were euthanized by an in-
traperitoneal injection of 0.2 ml Beuthanasia-D Special
(Schering-Plough, Union, NJ) immediately following ex-
posure on the 21st day. In the second part of the experi-
ment, eight female BALB/c mice were exposed to BDS
and seven female mice were exposed to HEPA-filtered
air for 21 days as described above, and were allowed
to recover for 10 days before they were euthanized.
Additionally, we exposed four female BALB/c mice by
inhalation to either filtered air or BDS (5 mg/m3;
4 h/day; for four consecutive days) to confirm our
previously published data [40]. This in turn provided
for the present study, a comparison time-point to
identify gene expression and related protein expression as-
sociated with early pulmonary responses. This allowed us
to determine the temporal expression of selected genes
and proteins associated with mechanisms related to satur-
ation processes and biotransformation phases.
Lung sample collection and processing
Following euthanasia, the lungs were lavaged twice with
0.5 mL phosphate-buffered saline passed through a 19-
gauge cannula anchored in the trachea. Pooled broncho-
alveolar lavage fluid (BALF) was immediately placed on
ice. Three-hundred cell differential counts were performed
on modified Wright’s-stained cytocentrifuge slide prepara-
tions of 400 μL aliquots of raw BALF. Levels of the BALF
cytokines IFN-γ, IL-1β, IL-6, IL-10, IL-12p70, KC/GRO/
CINC, and TNF-α were assayed with the Mouse ProIn-
flammatory 7-Plex Ultra-Sensitive Kit (Meso Scale Diag-
nostics, Rockville, Maryland). The lower limit of detection
for all the cytokines ranged from 0.38–35 pg/mL. This
assay was performed as specified by the manufacturer.
Histopathology
The right lung of each mouse (that was previously
lavaged) was perfused with 0.4 mL of freshly prepared
0.02 M periodate-0.1 M lysine-0.25 % paraformaldehyde
(PLP) fixative in phosphate buffer (pH 7.4), then excised
and stored in PLP for 24–48 h before standard histo-
logical processing, sectioning and hematoxylin-eosin
staining. Slides containing sections of 3 major lobes of
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the right lungs were coded randomly. They were then
evaluated by an experienced veterinary pathologist with
expertise in pulmonary pathology. Initially, all slides
were scored at 20 × and 100 × magnifications to deter-
mine overall inflammatory cellularity. In this study, all
responses were either normal or with a mild increase in
cellularity. Then, eight slides, four normal and four
mildly-increased, were evaluated in detail to determine
the gradient of changes present in specific anatomical
subunits of the lungs. If no gradient could be detected,
they were not scored (for example, bronchi and pleura
in this study). If an intensity gradient was detected, it
was scored on an arbitrary 0–3 scale with 0 = normal, =
1 mild change, 2 =moderate change, 3 = severe change
(with overall cellularity not exceeding mild, no severe
changes were detected in any subdivision). The approxi-
mate values for these scores are as follows:
Epithelial damage
Normal = none. Mild = 2 or fewer contiguous epithelial
cells with cytopathology, attenuation, or sloughing at
few, scattered sites. Moderate = 3–10 contiguous epithe-
lial cells with cytopathology, attenuation, or sloughing at
few, scattered sites, or frequent mild changes. Severe =
multiple denuded areas of bronchiolar/bronchial mucosa
with attenuation or regeneration of adjacent epithelial
cells or frequent moderate changes.
Mucosal inflammation (bronchioles)
0 = normal. Bronchus-associated lymphoid tissue (BALT)
aggregates were in small clusters in the branch-angles
and/or the combination of lymphocytes, plasma cells,
and eosinophils did not exceed ~10 per linear, 600×
field. 1 =mild increase. BALT aggregates were larger or
rare outside the branch-angles and/or lymphocytes,
plasma cells and eosinophils exceeded ~10 per linear
600× field but did not form clusters. 2 = moderate in-
crease. BALT aggregates outside the branch angles were
seen in multiple areas and/or lymphocytes, plasma cells
and/or eosinophils were seen in clusters in the sub-
mucosa. 3 = severe increase. Large BALT aggregates
common along bronchioles and/or diffuse infiltrates of
lymphocytes, plasma cells, and eosinophils.
Neutrophils
0 = normal. Neutrophils did not exceed 1–2 per linear,
600× field. 1 =mild increase. Neutrophils were 2–10 per
linear 600× field but did not form clusters. Transmucosal
exocytosis was rare. 2 =moderate increase. Neutrophils
exceeded 10 per linear 600× field and were frequently seen
in clusters in the submucosa. Transmucosal exocytosis
evident but not widespread. 3 = severe increase. Diffuse in-
filtrates of neutrophils were present and transmucosal
exocytosis was common. Similar parameters were estab-
lished for interstitial and alveolar inflammation.
RNA isolation
The excised left lung from each mouse (that was previ-
ously lavaged) was preserved in RNAlater (Applied Bio-
systems, Foster City, CA). Lungs were then removed
from the RNAlater solution, and after gentle blotting,
were placed into a separate clean 2 mL microcentrifuge
tube with 1 mL TRIzol Reagent (Invitrogen, Carlsbad,
CA) and a 4.5 mm copper-coated bead. The lung tissue
was homogenized with two 2-min 25-Hz passages on a
Mixer Mill MM300 (Qiagen, Valencia, CA). RNA was
purified from the aqueous phase of the lung homogenate
with the Qiagen RNeasy Mini Kit, including RNase-free
DNase treatment, according to the manufacturer’s
protocol. We measured RNA concentrations with a
NanoDrop ND-1000 Spectrophotometer (Wilmington,
DE). Values generated from the NanoDrop for all samples
fell into the following ranges: 260/280 ratio: 2.10–2.18;
260/230 ratio: 2.01–2.26; concentration: 1056–2969 ng/
μL. RNA quality and integrity was assessed for 1:5 dilu-
tions of each lung sample with the Agilent RNA 6000
Nano Assay Kit and the Agilent 2100 BioAnalyzer (Santa
Clara, CA). All samples fell within the following ranges:
28S/18S ratio: 1.0–1.7; RNA integrity # 7.8–9.7. Total
RNA was converted to cDNA with a High Capacity cDNA
Archive Kit (Applied Biosystems; Foster City, CA) accord-
ing to the manufacturer’s protocol.
Microarray assay
MouseGenome 430 2.0 Arrays (Affymetrix, Santa Clara,
CA) representing > 39,000 transcripts with > 45,000 probe
sets were used to assess global gene expression individu-
ally in the left lungs from each of four mice/group. Sam-
ples were selected for microarray assay based on RNA
concentration and on the scores from the Agilent BioAna-
lyzer results above. The arrays were processed at the Re-
search Core Facility of Louisiana State University Health
Science Center-Shreveport.
Double-stranded cDNA synthesized from total RNA
was used to create cRNA, which was biotinylated, frag-
mented, and added to a hybridization cocktail that in-
cluded probe array controls, bovine serum albumin, and
herring sperm DNA. This cocktail was hybridized (16 h;
45 °C) to oligonucleotide probes on microarrays in a
GeneChip Hybridization Oven 640. Immediately after
hybridization, the array underwent an automated wash-
ing and staining protocol on a GeneChip Fluidics Station
and was scanned with a GeneChip Scanner 3000. Collec-
tion and processing of initial raw data were performed
by a GeneChip Workstation. All gene chips and instru-
mentation were from Affymetrix (Santa Clara, CA). All
data collected and analyzed here adhere to the guidelines
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for Minimal Information About a Microarray Experi-
ment (MIAME).
Gene expression analysis
The .cel files from the GeneChip Workstation data were
processed by Expression Analysis Systems (Durham,
NC). A principal component analysis was generated to
assess clustering of experimental units. Mal performing
probes were removed from the data set by REDI (reduc-
tion of invariant probes) and a false discovery rate (FDR)
was determined by PADE (permutation analysis for dif-
ferential expression). Expression data for each transcript
including transcript p-value, FDR, fold change, Affyme-
trix probe ID, gene symbol and function were recorded.
Gene expression clusters were analyzed with DAVID
[91]. Heatmaps were produced using CIMminer of the
Genomics and Bioinformatics Group, Developmental
Therapeutics Branch (DTB), Developmental Therapeu-
tics Program (DTP), Center for Cancer Research (CCR),
U.S. National Cancer Institute (NCI).
Pathway analyses
Gene expression data were analyzed with Ingenuity
Pathway Analysis (Qiagen, Ingenuity Systems, Redwood
City, CA). As described previously [40, 41, 92], the most
significantly-enriched gene networks and canonical path-
ways (p < 0.05) were examined with the Ingenuity Analysis
Knowledge Database. We further created custom gene
networks to demonstrate the connections between the
genes and significantly associated functional networks and
signaling pathways.
Quantitative real time RT-PCR
Quantitative RT-PCR (qRT-PCR) was performed on
cDNA samples from lung homogenates with inventoried
TaqMan Gene Expression Assays primer-probe sets (Ap-
plied Biosystems) for a selection of genes. cDNA samples
from all mice in each group were assayed by qRT-PCR, re-
gardless of whether or not those mouse cDNAs previously
underwent microarray analysis. Reaction volumes were
25 μL, and 40 reaction cycles were run for each gene in an
Applied Biosystems 7300 Real-Time PCR System. Relative
gene expression was determined by the comparative cycle
threshold (ΔΔCT) method, with each gene normalized to
hypoxanthine guanine phosphoribosyltransferase (Hprt1)
expression [93], and then compared to the air controls. Re-
sults are reported as fold change over control [(2-ΔΔCT)].
Extraction of proteins
Proteins were extracted from frozen lung tissue (stored
at -80 °C) collected from experimental and control ani-
mals, exposed to either HEPA-filtered air or 5 mg/m3 of
BDS for 4 h a day for 4 days. Tissues placed inside
aluminum foil were snap-frozen in liquid nitrogen,
mechanically broken by light hammering, and quickly
placed into 2 mL round bottom micro-centrifuge tubes
containing 300 μL of RIPA lysis buffer (Santa Cruz Bio-
technology, Dallas, TX, USA), and three 2.5 mm zirco-
nia/silica beads (Biospec Products Inc.). Tissues were
lysed completely with the aid of TissueLyser II (Qiagen,
USA) at 25 MHz for 2 min. The lysed tissue was centri-
fuged at 13,000 g for 5 min at 4 °C. Proteins in the
supernatants were aliquoted and stored at -80 °C. BCA
protein assay kits (Thermo Scientific, Waltham, MA,
USA) were used to determine protein concentrations in
the lung supernatants.
Western blotting
Fifteen micrograms of protein extracts from each of
eight lung tissues (four from controls exposed to HEPA-
filtered air and four from exposed mice that inhaled
BDS at 5 mg/m3 for 4 h a day for 4 days) were incubated
in Laemmli buffer (Bio Rad Laboratories Inc., Hercules,
CA, USA) with 2-mercaptoethanol, heated for 95 °C for
5 min in a PCR machine, and resolved by SDS-PAGE on
Any kD™ Mini-PROTEAN® TGX™ Gel (Bio-Rad Labora-
tories, Inc., Hercules, CA, USA) at 100 volts until ex-
pected separation of proteins was obtained. Proteins
resolved on the gels were transferred onto PVDF mem-
branes (Immobilon-P, pore size of 0.45 μm, Millipore
Inc., USA) with the Trans-Blot Turbo™ Trransfer System
(Bio-Rad Laboratories, Hercules, CA, USA). Antibodies
to β-actin (ACTB), which was used as the control, and
NAD(P)H quinone oxidoreductase 1 (NQO1) were pur-
chased from Cell Signaling Technology Inc., (Danvers,
MA, USA). Antibodies to cytochrome P450 1A1
(CYP1A1), and cytochrome P450 1B1 (CYP1B1) were
from Santa Cruz Biotechnology, Inc., (Dallas, TX, USA).
The aldehyde dehydrogenase 3A1 (ALDH3A1) antibody
was obtained from Thermo-Fisher Scientific Inc.,
(Waltham, MA, USA). All antibodies were diluted in
blocking buffer made with 1× TBS (Bio-Rad Labora-
tories) supplemented with 1 % bovine serum albumin
(Immucor Inc., Norcross, GA), and 0.1 % Tween 20
(Bio-Rad Laboratories). Immunoblots were detected
with the aid of the ECL-Prime Western Blotting De-
tection reagent (GE Healthcare, UK). Western blot
images were captured by with ChemiDoc™ Touch im-
aging system (Bio-Rad Laboratories, Hercules, CA, USA),
and the captured images were analyzed with Image Lab
5.2 (Bio-Rad Laboratories, Hercules, CA, USA). Experi-
ments were run in duplicate or triplicate.
Statistical analysis
We used UNIVARIATE and TTEST procedures of the
SAS statistical package (version 9.1.3; SAS Institute, Inc.,
Cary, NC) to compare BALF cytokine and qRT-PCR
data. We used a folded F-test for each data set to
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determine if the variances across the set were statistically
‘equal’, in which case the variances could be pooled for
determining statistical differences. For the occasional
cases of unequal variance across a data set, we used
Satterthwaite’s approximation of degrees of freedom to
determine statistical significance. We analyzed BALF cy-
tology results by ANOVA, followed by the Tukey test.
Statistical significance was achieved when p < 0.05.
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